ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,849.72
0.00%
US Tech 100
19,799.20
-0.42%
다우존스 지수
43,191.24
0.00%
Bitcoin
82,667.67
-3.98%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Travere Therapeutics Inc (TVTX) 시세

Travere Therapeutics Inc

Travere Therapeutics Inc (TVTX)

NASDAQ
19.80
-1.60
(-7.48%)
마감 04 3월 6:00AM
15분 지연
19.74
-0.06
( -0.30% )
시간외 단일가: 10:31PM
15분 지연

개인 투자자를 위한 전문가급 도구.

프리미엄

주요 통계 및 세부정보

가격
19.74
매수가
17.01
매도가
21.91
거래량
962
0.00 일간 변동폭 0.00
5.12 52주 범위 25.29
market_cap
1.752B
전일 종가
19.80
개장가
-
최근 거래 시간
1
@
19.8
마지막 거래 시간
23:02:55
재정 규모
-
VWAP
-
평균 볼륨(3m)
1,540,377
발행 주식
88,739,826
배당수익률
-
주가수익률
-5.46
주당순이익(EPS)
-3.62
매출
233.18M
순이익
-321.55M

Travere Therapeutics Inc 정보

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomer... Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often lead to end-stage kidney disease. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
travere.com
본부
Lewes, Delaware, USA
설립됨
-
Travere Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker TVTX. The last closing price for Travere Therapeutics was US$19.80. Over the last year, Travere Therapeutics shares have traded in a share price range of US$ 5.12 to US$ 25.29.

Travere Therapeutics currently has 88,739,826 shares in issue. The market capitalisation of Travere Therapeutics is US$1.76 billion. Travere Therapeutics has a price to earnings ratio (PE ratio) of -5.46.

TVTX 최신 뉴스

추가 뉴스

Form 8-K - Current report
Edgar (US Regulatory)
21 2월 2025
TVTX (-7.48%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
13 2월 2025
TVTX (-7.48%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
13 2월 2025
TVTX (-7.48%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
13 2월 2025
TVTX (-7.48%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-1.735-8.0791618160721.47521.9817.82173749020.74248589CS
4-0.5075-2.5064822817620.247525.2917.82206630122.18455514CS
120.814.2789223454818.9325.2916.588154037720.21930574CS
2610.23107.5709779189.5125.299.34172400517.58681348CS
5211.81148.9281210597.9325.295.12142446413.54496964CS
156-6.76-25.509433962326.530.355.12126625215.41604369CS
260-5.41-21.510934393625.1533.08995.12110240816.82684919CS

TVTX - Frequently Asked Questions (FAQ)

What is the current Travere Therapeutics share price?
The current share price of Travere Therapeutics is US$ 19.74
How many Travere Therapeutics shares are in issue?
Travere Therapeutics has 88,739,826 shares in issue
What is the market cap of Travere Therapeutics?
The market capitalisation of Travere Therapeutics is USD 1.76B
What is the 1 year trading range for Travere Therapeutics share price?
Travere Therapeutics has traded in the range of US$ 5.12 to US$ 25.29 during the past year
What is the PE ratio of Travere Therapeutics?
The price to earnings ratio of Travere Therapeutics is -5.46
What is the cash to sales ratio of Travere Therapeutics?
The cash to sales ratio of Travere Therapeutics is 7.54
What is the reporting currency for Travere Therapeutics?
Travere Therapeutics reports financial results in USD
What is the latest annual turnover for Travere Therapeutics?
The latest annual turnover of Travere Therapeutics is USD 233.18M
What is the latest annual profit for Travere Therapeutics?
The latest annual profit of Travere Therapeutics is USD -321.55M
What is the registered address of Travere Therapeutics?
The registered address for Travere Therapeutics is 16192 COASTAL HWY, LEWES, DELAWARE, 19958
What is the Travere Therapeutics website address?
The website address for Travere Therapeutics is travere.com
Which industry sector does Travere Therapeutics operate in?
Travere Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
MASS908 Devices Inc
US$ 3.47
(75.25%)
10.61M
UOKAMDJM Ltd
US$ 0.2285
(52.33%)
57.57M
CYCUCycurion Inc
US$ 0.7883
(31.14%)
31.32M
IKTInhibikase Therapeutics Inc
US$ 2.91
(28.19%)
31
SWAGStran and Company Inc
US$ 1.30
(27.45%)
22
EVCMEverCommerce Inc
US$ 6.20
(-36.28%)
7
SPGCSacks Parente Golf Inc
US$ 0.1218
(-35.89%)
25.23M
OPCHOption Care Health Inc
US$ 22.01
(-35.19%)
70
NVNINVNI Group Ltd
US$ 0.2535
(-32.16%)
9.82M
TNYATenaya Therapeutics Inc
US$ 0.65
(-31.35%)
738.08k
UOKAMDJM Ltd
US$ 0.2238
(49.20%)
57.62M
SUNESUNation Energy Inc
US$ 0.2025
(-15.63%)
53.21M
BTOGBit Origin Ltd
US$ 0.3623
(13.47%)
53.12M
CYCUCycurion Inc
US$ 0.7858
(30.73%)
31.33M
PTIXProtagenic Therapeutics Inc
US$ 0.3355
(21.43%)
28.39M

TVTX Discussion

게시물 보기
Monksdream Monksdream 2 일 전
TVTX under $25
👍️0
Monksdream Monksdream 6 월 전
TVTX under $15
👍️0
Monksdream Monksdream 8 월 전
TVTX under $10
👍️0
tw0122 tw0122 10 월 전
7.46 + 13% Looks good Caanacord $15 buy target. Once it breaks 9.83 on the way to $13. Probably take a few weeks and positive catalysts
👍️0
Monksdream Monksdream 10 월 전
TVTX under $10
👍️0
bikaver bikaver 1 년 전
TVTX.....In at 6.56
👍️0
bikaver bikaver 1 년 전
TVTX.....from 7.65 to 9.24 in 6 days
👍️0
bikaver bikaver 1 년 전
TVTX.....Gambling on a dead cat bounce.....in @ 7.65 AH.
👍️0
Stockexpertpro Stockexpertpro 1 년 전
Watching for the Collapse under 8$ This could get ugly today 7$ probably under 6$ Coming
👍️0
alchemytrader alchemytrader 4 년 전
Arent they all modern day drug dealers?
👍️0
cash4 cash4 4 년 전
Free Martin Shkreli, LMFAO, felon CEO with a 1,5 billion company trading at $32 PPS, you gotta love America, just another modern day Drug Dealer.
👍️0

최근 히스토리

NASDAQ
TVTX
Travere Therapeutics
BIT
P1SD31
BNP Paribas Issuance
BIT
P1QTH2
BNP Paribas Issuance
BIT
UI380C
Unicredit Bank
BIT
UC7PXF
Unicredit Bank
BIT
P1NUF1
BNP Paribas Issuance
BIT
UC72NC
Unicredit Bank
BIT
UR9QAQ
UniCredit Bank
BIT
UC8VMQ
Unicredit Bank
BIT
UC0W3B
Unicredit Bank
BIT
UB4QEL
Unicredit Bank
BIT
P1PW64
BNP Paribas Issuance
BIT
UC7C6J
Unicredit Bank
BIT
1SPCE
Virgin Galactic
BIT
1COST
Costco Wholesale
BIT
GCOR
Franklin Sustainable Eur...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지